Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Tenaya Therapeutics is a clinical-stage biotechnology company committed to a bold mission: to discover, develop, and deliver curative therapies that address the underlying causes of heart disease. They are focused on pioneering genetic medicines, including gene therapy, cellular regeneration, and precision medicine, to improve and save the lives of patients with heart conditions. Tenaya leverages its integrated capabilities in research, development, and manufacturing to advance its pipeline of potentially transformative treatments.
Serves as the central hub for research and development, cGMP manufacturing, corporate operations, and executive leadership.
State-of-the-art laboratories for gene therapy research, process development, and in-house cGMP manufacturing capabilities for AAV-based gene therapies.
A science-driven, innovative, and collaborative environment focused on tackling complex challenges in cardiovascular disease. Employees are often mission-oriented, dedicated to patient impact.
Located in a prominent biotechnology hub, providing access to talent, research institutions, and industry partners. The co-location of R&D and manufacturing allows for integrated and efficient drug development.
Tenaya Therapeutics' core operations, including research, development, and manufacturing, are primarily based in the United States (South San Francisco, CA). While their physical office presence is centralized, their clinical trials may involve sites across North America and potentially expand globally as programs mature. Their strategic collaborations and future commercialization efforts may also extend their reach internationally.
1000 Gateway Boulevard
South San Francisco
CA
United States
Address: 1000 Gateway Boulevard, South San Francisco, CA 94080 (Co-located/Part of HQ Campus)
Supports the company's pipeline by providing control over manufacturing processes, quality, and supply chain for its novel gene therapy candidates. Essential for advancing products through clinical development stages.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Tenaya Therapeutics' leadership includes:
Tenaya Therapeutics has been backed by several prominent investors over the years, including:
Tenaya Therapeutics has made several key appointments to its executive team in the past 12-18 months, strengthening its leadership in commercial, legal, and business operations. No prominent executive exits have been publicly announced during this period.
Discover the tools Tenaya Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Tenaya Therapeutics primarily uses the 'firstinitiallast' email format. Understanding this common pattern can be useful for professional communication.
flast@tenayathera.com
Format
jdoe@tenayathera.com
Example
85%
Success rate
Tenaya Therapeutics Press Release • March 12, 2024
Tenaya announced the appointment of Mohamad H. Sater, M.D., Ph.D., as Chief Commercial Officer. Dr. Sater brings extensive experience in global commercial strategy and product launches in rare diseases and cardiology....more
Tenaya Therapeutics Press Release • February 28, 2024
Tenaya provided updates on its gene therapy pipeline, including progress on TN-201 for MYBPC3-Associated HCM, TN-401 for PKP2-Associated ARVC, and its cGMP manufacturing capabilities. Financial results for Q4 and FY2023 were also reported....more
Tenaya Therapeutics Press Release • January 8, 2024
Tenaya outlined its strategic priorities for 2024, focusing on advancing its clinical-stage programs, leveraging its manufacturing capabilities, and progressing its preclinical research....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Tenaya Therapeutics, are just a search away.